
|Articles|November 1, 2012
Merck Moves Forward with Plans for Vorapaxar Approval
Anticoagulation therapies reviewed, including Merck moving forward with FDA approval of vorapaxar despite bleeding risks
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacist Involvement Speeds Prior Authorization for GLP-1s
2
Navigating Compounding Peptides and GLP-1s Through Regulations
3
FDA Approves Autoinjector of Lerodalcibep-Liga With Updated Indication
4
The 2026 GLP-1 Compounding Crackdown: A Pharmacist’s Guide
5



























